Physical Laboratory Automation in Synthetic Biology.

automation design-build-test-learn microfluidics robotics standardization synthetic biology

Journal

ACS synthetic biology
ISSN: 2161-5063
Titre abrégé: ACS Synth Biol
Pays: United States
ID NLM: 101575075

Informations de publication

Date de publication:
17 11 2023
Historique:
medline: 20 11 2023
pubmed: 7 11 2023
entrez: 7 11 2023
Statut: ppublish

Résumé

Synthetic Biology has overcome many of the early challenges facing the field and is entering a systems era characterized by adoption of Design-Build-Test-Learn (DBTL) approaches. The need for automation and standardization to enable reproducible, scalable, and translatable research has become increasingly accepted in recent years, and many of the hardware and software tools needed to address these challenges are now in place or under development. However, the lack of connectivity between DBTL modules and barriers to access and adoption remain significant challenges to realizing the full potential of lab automation. In this review, we characterize and classify the state of automation in synthetic biology with a focus on the physical automation of experimental workflows. Though fully autonomous scientific discovery is likely a long way off, impressive progress has been made toward automating critical elements of experimentation by combining intelligent hardware and software tools. It is worth questioning whether total automation that removes humans entirely from the loop should be the ultimate goal, and considerations for appropriate automation versus total automation are discussed in this light while emphasizing areas where further development is needed in both contexts.

Identifiants

pubmed: 37935025
doi: 10.1021/acssynbio.3c00345
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3156-3169

Auteurs

Ashley Stephenson (A)

Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, Washington 98195, United States.
Microsoft Research, Redmond, Washington 98052, United States.

Lauren Lastra (L)

Microsoft Research, Redmond, Washington 98052, United States.

Bichlien Nguyen (B)

Microsoft Research, Redmond, Washington 98052, United States.

Yuan-Jyue Chen (YJ)

Microsoft Research, Redmond, Washington 98052, United States.

Jeff Nivala (J)

Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, Washington 98195, United States.

Luis Ceze (L)

Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, Washington 98195, United States.

Karin Strauss (K)

Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, Washington 98195, United States.
Microsoft Research, Redmond, Washington 98052, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH